Helping you achieve success
We are dedicated to helping you achieve, fast, accurate, and cost-effective hematology testing.
The healthcare system’s ability to adapt to growing inpatient volumes relies on its ability to manage resource allocation decisions and ensure that the appropriate level of care is provided.
Although there is not a specific flag or indicator for COVID-19, common parameters that are found on hematology analyzers may be used to assess the condition of patients diagnosed with COVID-19. By monitoring changes in results over time along with other clinical indicators, clinicians can identify patients that may require an escalation of care. Hematology analyzers can be scalable to meet your organization’s evolving needs. Small, compact systems that deliver CBC with WBC Differential results in a matter of minutes to high-throughput instruments that can generate hundreds of results within an hour. Advanced connectivity capabilities also support ease of patient analysis and an assessment of trend data.
Abbott offers a family of solutions, depending on your hematology testing needs.
Easy-to-use, benchtop systems that perform a CBC with either 3- or 5-part WBC differential analysis.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.